Medical Director, GI Oncology and Solid Tumors

About the role

For our client, we are seeking a Medical Director, GI Oncology and Solid Tumors to join the team of a leader in the Pharmaceuticals & Biotech space. This role will help shape the medical strategy for an oncology portfolio, with a focus on gastrointestinal and solid tumor disease areas. The position partners closely with cross-functional teams to support scientific communications, clinical insights, and brand-informed medical decision‑making. It also requires engagement with external experts and internal stakeholders to advance medically sound programs and support healthcare provider needs. Location: Remote – US‑based candidates only, no visa sponsorship available.

Responsibilities

• Collaborate with a matrix medical affairs team to develop a scientific platform and medical strategic plan.
• Provide clinical and medical guidance on joint projects with the medical affairs team and other departments.
• Contribute to publication strategy and review manuscripts and abstracts for scientific meetings.
• Engage with clinical and commercial teams to inform brand strategies.
• Participate in investigator‑sponsored trial review and educational grant processes.
• Support inquiries from healthcare professionals and managed care organizations.
• Ensure medical affairs presentations are accurate and clinically meaningful.

Qualifications

• Advanced degree (MD, DO, Ph.D., Pharm.D. or equivalent) required.
• Oncology experience, preferably in GI tumors and breast cancer.
• 5‑10 years in medical affairs or similar roles in a pharmaceutical company or equivalent clinical tenure in oncology.
• Excellent verbal and written communication skills.
• Proven ability to collaborate with internal teams in sales, marketing, and managed care.
• Demonstrated ability to build relationships with key opinion leaders.
• Self‑starter with a positive attitude.

Benefits

• Medical, dental, and vision insurance.
• 401(k) retirement savings plan.
• Flexible paid vacation.
• Discretionary annual cash bonus or incentive compensation.
• Discretionary equity grants.

Pay

$216,000 – $324,000 annually